Daunorubicin in the therapy of acute granulocytic leukemia
Weil, M.; Glidewell, O.J.; Jacquillat, C.; Levy, R.; Serpick, A.A.; Wiernik, P.H.; Cuttner, J.; Hoogstraten, B.; Wasserman, L.; Ellison, R.R.; Gailani, S.; Brunner, K.; Silver, R.T.; Rege, V.B.; Cooper, M.R.; Lowenstein, L.; Nissen, N.I.; Haurani, F.; Blom, J.; Boiron, M.; Bernard, J.; Holland, J.F.
Cancer Research 33(5): 921-928
1973
ISSN/ISBN: 0008-5472 PMID: 4512953 Document Number: 69352
Document emailed within 1 workday
Related Documents
Wiernik, P.H.; Schimpff, S.C.; Schiffer, C.A.; Lichtenfeld, J.L.; Aisner, J.; O'connell, M.J.; Fortner, C. 1976: Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia Cancer Treatment Reports 60(1): 41-53Burns, C.P. 1975: Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia Cancer ChemoTherapy Reports 59(4): 757-760
Haruyama, H.; Shimazaki, C.; Nakanishi, S.; Hamami, T.; Nisio, A.; Isemura, T.; Katsume, H.; Nakagawa, M.; Ijichi, H. 1982: Cardiotoxicity of daunorubicin and aclacinomycin a in patients with acute leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(3): 516-521
Tricot, G.; Weber, G. 1996: Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity Anticancer Research 16(6a): 3341-3347
Bernard, J.; Jacquillat, C.; Boiron, M.; Weil, M.; Gémon, M.F.; Izrael, V.; Schaison, G.; Delobel, J. 1972: 57 cases of acute leukemia. Trial treatment with a semisynthetic daunorubicin derivative: 22,050 R.P La Nouvelle Presse Medicale 1(33): 2149-2152
Weil, M.; Jacyuillat, C.I.; Gemon-Auclerc, M.F.; Chastang, C.L.; Izrael, V.; Boiron, M.; Bernard, J. 1976: Acute granulocytic leukemia: treatment of the disease Archives of Internal Medicine 136(12): 1389-1395
Mantel, N. 1983: Responder versus nonresponder comparisons: daunorubicin plus prednisone in treatment of acute nonlymphocytic leukemia Cancer Treatment Reports 67(3): 315-316
Karoui, M.; Hafsia, A.; Boussen, M. 1987: Acute granulocytic leukemia in children. Apropos of 51 cases La Tunisie Medicale 65(2): 97-102
Fiel, I.; Strauchen, J.A.; LoValvo, R.; Meyer, R.J.; Unger, P.D. 1995: Acute granulocytic leukemia with ascites as the initial manifestation Acta Cytologica 39(3): 608-609
Schwartsmann, G.; Fernandes, M.S.; Schaan, M.D.; Moschen, M.; Gerhardt, L.M.; Di Leone, L.; Loitzembauer, B.; Kalakun, L. 1997: Decitabine (5-Aza-2'-deoxycytidine; DAC) plus daunorubicin as a first line treatment in patients with acute myeloid leukemia: preliminary observations Leukemia 11(Suppl 1): S28-S31
Vogler, W.R.; Velez-Garcia, E.; Omura, G.; Raney, M. 1989: A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia Seminars in Oncology 16(1 Suppl 2: 21-24
Perilov, A.A.; Volkova, M.A.; Frenkel', M.A. 1989: Late results of the treatment of acute granulocytic leukemia in adults Terapevticheskii Arkhiv 61(7): 8-11
Dufour, C.; Garaventa, A.; Brisigotti, M.; Rosanda, C.; Mori, P.G. 1995: Massively diffuse multifocal granulocytic sarcoma in a child with acute myeloid leukemia Tumori 81(3): 222-224
Basa, J.; Wolska-Smoleń, T.; Walter, Z.; Skotnicki, A.B. 2006: Granulocytic sarcoma with late transformation into acute myeloblastic leukemia--case report Przeglad Lekarski 63(8): 706-710
Chouchary, D.R.; Bhattacharya, M.; Mishtra, P.; Mahapatra, M.; Kumar, R. 2006: Granulocytic sarcoma of spine: an unusual initial presentation of acute myeloid leukemia Journal of the Association of Physicians of India 54: 897
Takemoto, Y.; Sampi, K.; Kuraishi, Y.; Okabe, K.; Tamura, K.; Mizoguchi, H.; Saito, H.; Masaoka, T.; Ogawa, M. 1999: A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. the KRN8602 Leukemia Study Group International Journal of Hematology 70(1): 20-25
Berman, E.; Arlin, Z.A.; Gaynor, J.; Miller, W.; Gee, T.; Kempin, S.J.; Mertelsmann, R.; Andreeff, M.; Reich, L.; Nahmias, N. 1989: Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol Leukemia 3(2): 115-121
Khunger, J.M.; Sharma, M.P.; Talib, V.H. 2000: Granulocytic sarcoma of humerus, an unusual association of acute myeloblastic leukemia--a case report Indian Journal of Pathology and Microbiology 43(4): 475-478
Avigdor, S.; du Rouchet, E.; Michenet, P.; Grossetti, D.; Lucas, V. 1991: The presence of an ovarian granulocytic sarcoma concurrent with a type M2 acute myeloblastic leukemia: a case Journal de Gynecologie Obstetrique et Biologie de la Reproduction 20(6): 797-801
Taguchi, H.; Kubonishi, I.; Takehara, N.; Uemura, Y.; Iwahara, Y.; Eguchi, T.; Miyagi, T.; Sugito, S.; Muneishi, H.; Tanaka, Y. 1992: Intensive induction chemotherapy of adult acute myelogenous leukemia by continuing daunorubicin, behenoyl-cytosine arabinoside, 6-mercaptopurine and prednisolone until marrow aplasia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(9): 1309-1314